RGNX · Categories · Form 4

RGNX - SEC Form 4 insider transactions

REGENXBIO Inc. (RGNX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for RGNX

• 49d
  Chief Medical Officer Pakola Steve sold $53,033 worth of shares (5,124 units at $10.35), decreasing direct ownership by 2% to 247,926 units (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 86d
  Chief Strategy & Legal Officer Christmas Patrick J. covered exercise/tax liability with 4,700 shares, decreasing direct ownership by 2% to 210,667 units (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 86d
  Chief Medical Officer Pakola Steve covered exercise/tax liability with 5,267 shares, decreasing direct ownership by 2% to 253,050 units (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 91d
  Director Mills Kenneth T. exercised 225,000 shares at a strike of $13.09 and covered exercise/tax liability with 221,753 shares, increasing direct ownership by 0.67% to 486,118 units (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 112d
  Chief Medical Officer Pakola Steve was granted 65,847 shares, increasing direct ownership by 34% to 258,317 units (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 112d
  Chief Technology Officer Malzahn Craig was granted 65,847 shares, increasing direct ownership by 403% to 82,194 units (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 112d
  Chief Executive Officer Simpson Curran was granted 144,864 shares, increasing direct ownership by 73% to 342,467 units (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 112d
  Chief Strategy & Legal Officer Christmas Patrick J. was granted 73,749 shares, increasing direct ownership by 52% to 215,367 units (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 112d
  Chief Financial Officer Chan Mitchell was granted 73,749 shares, increasing direct ownership by 137% to 127,717 units (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 114d
  Chief Executive Officer Simpson Curran covered exercise/tax liability with 18,559 shares, decreasing direct ownership by 9% to 197,603 units (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 114d
  Chief Technology Officer Malzahn Craig covered exercise/tax liability with 1,238 shares, decreasing direct ownership by 7% to 16,347 units (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 114d
  Chief Strategy & Legal Officer Christmas Patrick J. covered exercise/tax liability with 9,793 shares, decreasing direct ownership by 6% to 141,618 units (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 114d
  Chief Medical Officer Pakola Steve covered exercise/tax liability with 18,247 shares, decreasing direct ownership by 9% to 192,470 units (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 202d
  Chief Executive Officer Simpson Curran sold $262,635 worth of shares (20,811 units at $12.62), decreasing direct ownership by 9% to 216,162 units (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 211d
  Chief Executive Officer Simpson Curran sold $76,469 worth of shares (7,624 units at $10.03), decreasing direct ownership by 3% to 236,973 units (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 230d
  Chief Executive Officer Simpson Curran sold $77,495 worth of shares (7,734 units at $10.02), decreasing direct ownership by 3% to 244,597 units (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 239d
  Chief Technology Officer Malzahn Craig covered exercise/tax liability with 234 shares, decreasing direct ownership by 1% to 17,585 units (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 239d
  Chief Financial Officer Chan Mitchell covered exercise/tax liability with 4,901 shares, decreasing direct ownership by 8% to 53,968 units (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 269d
  Chief Strategy & Legal Officer Christmas Patrick J. covered exercise/tax liability with 4,699 shares, decreasing direct ownership by 3% to 151,411 units (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 301d
  Chief Executive Officer Simpson Curran covered exercise/tax liability with 4,701 shares, decreasing direct ownership by 2% to 252,331 units (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 331d
  Director Fox Allan M. was granted 7,768 shares, increasing direct ownership by 69% to 19,054 units (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 331d
  Director Zachary Jennifer was granted 7,768 shares, increasing direct ownership by 54% to 22,064 units (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 331d
  Director Tasse Daniel was granted 7,768 shares, increasing direct ownership by 69% to 19,054 units (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 331d
  Director Stump David C was granted 7,768 shares, increasing direct ownership by 69% to 19,054 units (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 331d
  Director Mills Kenneth T. was granted 7,768 shares, increasing direct ownership by 2% to 482,871 units (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 331d
  Director Migausky George V was granted 7,768 shares, increasing direct ownership by 69% to 19,054 units (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 331d
  Director Glucksmann Alexandra was granted 7,768 shares, increasing direct ownership by 69% to 19,054 units (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 331d
  Director Karabelas Argeris N was granted 7,768 shares, increasing direct ownership by 69% to 19,054 units (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 331d
  Director Bennett Jean was granted 7,768 shares, increasing direct ownership by 69% to 19,054 units (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 351d
  Director Mills Kenneth T. exercised 20,602 shares at a strike of $3.76 and sold $163,046 worth of shares (20,602 units at $7.91) (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 391d
  Chief Legal Officer Christmas Patrick J. covered exercise/tax liability with 4,700 shares, decreasing direct ownership by 3% to 156,110 units (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 391d
  Chief Medical Officer Pakola Steve covered exercise/tax liability with 5,263 shares, decreasing direct ownership by 2% to 210,717 units (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 391d
  Chief Scientific Officer Danos Olivier covered exercise/tax liability with 5,452 shares, decreasing direct ownership by 2% to 226,348 units (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 395d
  Director Mills Kenneth T. exercised 30,752 shares at a strike of $3.76, increasing direct ownership by 7% to 475,103 units (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 471d
  Amendment: SEC Form 4 filed by Chief Executive Officer Simpson Curran

  4/A - REGENXBIO Inc. (0001590877) (Issuer)
• 479d
  Chief Medical Officer Pakola Steve covered exercise/tax liability with 13,891 shares and was granted 64,293 shares, increasing direct ownership by 30% to 215,980 units (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 479d
  Chief Scientific Officer Danos Olivier was granted 59,347 shares and covered exercise/tax liability with 12,630 shares, increasing direct ownership by 25% to 231,800 units (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 479d
  Chief Executive Officer Simpson Curran covered exercise/tax liability with 11,917 shares and was granted 98,912 shares, increasing direct ownership by 51% to 257,032 units (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 479d
  Chief Legal Officer Christmas Patrick J. covered exercise/tax liability with 11,395 shares, decreasing direct ownership by 7% to 160,810 units (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 479d
  SEC Form 4 filed by Chief Financial Officer Chan Mitchell

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 575d
  Director Karabelas Argeris N exercised 10,000 shares at a strike of $3.76 and sold $101,052 worth of shares (10,000 units at $10.11) (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 589d
  Chief Financial Officer Chan Mitchell was granted 58,869 shares (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 603d
  Director Karabelas Argeris N exercised 10,000 shares at a strike of $3.76 and sold $115,588 worth of shares (10,000 units at $11.56) (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 626d
  Director Mills Kenneth T. exercised 36,316 shares at a strike of $0.85, increasing direct ownership by 9% to 444,351 units (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 633d
  Chief Medical Officer Pakola Steve was granted 58,386 shares, increasing direct ownership by 54% to 165,578 units (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 633d
  Chief Legal Officer Christmas Patrick J. was granted 56,446 shares, increasing direct ownership by 49% to 172,205 units (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 633d
  Director Karabelas Argeris N sold $136,454 worth of shares (10,100 units at $13.51) and exercised 10,100 shares at a strike of $3.85 (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 633d
  Chief Executive Officer Simpson Curran sold $1,500 worth of shares (100 units at $15.00), decreasing direct ownership by 0.06% to 170,037 units (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 633d
  Chief Scientific Officer Danos Olivier was granted 60,230 shares, increasing direct ownership by 48% to 185,083 units (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 639d
  Director Karabelas Argeris N exercised 11,000 shares at a strike of $12.74 and sold $165,495 worth of shares (11,000 units at $15.04) (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 639d
  Chief Executive Officer Simpson Curran sold $145,106 worth of shares (9,648 units at $15.04), decreasing direct ownership by 5% to 170,137 units (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 643d
  Director Mills Kenneth T. exercised 27,590 shares at a strike of $3.76 and sold $382,934 worth of shares (27,590 units at $13.88) (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 651d
  Director Mills Kenneth T. exercised 2,410 shares at a strike of $3.76 and sold $33,192 worth of shares (2,410 units at $13.77) (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 667d
  Chief Executive Officer Simpson Curran was granted 56,458 shares, increasing direct ownership by 46% to 179,785 units (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 667d
  Director Karabelas Argeris N exercised 10,000 shares at a strike of $3.76 and sold $112,691 worth of shares (10,000 units at $11.27) (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 695d
  Zachary Jennifer was granted 4,790 shares, increasing direct ownership by 50% to 14,296 units (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 695d
  Migausky George V was granted 4,790 shares, increasing direct ownership by 74% to 11,286 units (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 695d
  Karabelas Argeris N was granted 4,790 shares, increasing direct ownership by 74% to 11,286 units (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 695d
  Glucksmann Alexandra was granted 4,790 shares, increasing direct ownership by 74% to 11,286 units (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)
• 695d
  Bennett Jean was granted 4,790 shares, increasing direct ownership by 74% to 11,286 units (SEC Form 4)

  4 - REGENXBIO Inc. (0001590877) (Issuer)

Other RGNX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends